Open AccessEfficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection
Author(s) -
Kaili Wang,
Han-Qian Xing,
Hong Zhao,
Jun-Wei Liu,
Deng-Lian Gao,
Xuehua Zhang,
Hongxun Yao,
Yan Li,
Jing Zhao
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i14.4071
Subject(s) - tolerability , medicine , adverse effect , leukopenia , gastroenterology , ribavirin , nausea , pegylated interferon , hemodialysis , hepatitis c virus , hepatitis c , surgery , immunology , virus , chemotherapy
To evaluate the efficacy and tolerability of low-dose standard or pegylated interferon (PEG-IFN) in hepatitis C virus (HCV)-positive hemodialysis patients.